BCHE and early-onset autosomal dominant Alzheimer disease: Therefore, cholinesterase inhibition is an effective therapeutic approach for the treatment of a variety of cholinesterase-related diseases, such as Alzheimer’s disease (AD), glaucoma, or to antagonize muscle relaxation (Cavallaro et al., 2018).